NCT00958074 2018-10-18Vorinostat in Patients With Primary Cutaneous T-Cell LymphomaUniversity of WashingtonPhase 2 Terminated11 enrolled 11 charts
NCT01187446 2017-11-20Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis FungoidesStanford UniversityPhase 1/2 Terminated28 enrolled 13 charts
NCT00810576 2012-08-07Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 2 Terminated1 enrolled 3 charts
NCT01116154 2010-12-09Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaCity of Hope Medical CenterPhase 1 Terminated30 enrolled